| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |